ORCID as entered in ROS

Select Publications
2009, 'TCR β-chain sharing in human CD8+ T cell responses to cytomegalovirus and EBV', Journal of Immunology, 181, pp. 7853 - 7862, http://dx.doi.org/10.4049/jimmunol.181.11.7853
,2009, 'P12-01. Construction and characterization of recombinant envelope glycoproteins derived from HIV-1 pre-seroconversion strains as potential vaccine immunogens', Retrovirology, 6, pp. P167, http://dx.doi.org/10.1186/1742-4690-6-S3-P167
,2009, 'Construction and characterization of recombinant envelope glycoproteins derived from HIV-1 pre-seroconversion strains as potential vaccine immunogens', RETROVIROLOGY, 6, http://dx.doi.org/10.1186/1742-4690-6-S3-P167
,2009, 'Does the presence of anti-HIV miRNAs in monocytes explain their resistance to HIV-1 infection?', Blood, 113, pp. 5029 - 5030, http://dx.doi.org/10.1182/blood-2009-01-196741
,2009, 'A culture amplified multi-parametric intracellular cytokine assay (CAMP-ICC) for enhanced detection of antigen specific T-cell responses', Journal of Immunological Methods, 345, pp. 1 - 16
,2009, 'Evolution of CD4+T cell count in HIV-1-infected adults receiving antiretroviral therapy with sustained long-term virological suppression', AIDS Research and Human Retroviruses, 25, pp. 569 - 576
,2009, 'High levels of human antigen-specific CD4+ T cells in peripheral blood revealed by stimulated coexpression of CD25 and CD134 (OX40)', Journal of Immunology, 183, pp. 2827 - 2836, http://dx.doi.org/10.4049/jimmunol.0803548
,2009, 'HLA Footprints on human immunodeficiency virus tp 1 are associated with interclade polymorphisms and intraclade phylogenetic clustering', Journal of Virology, 83, pp. 4605 - 4615, http://dx.doi.org/10.1128/JVI.02017-08
,2009, 'HLA Footprints on Human Immunodeficiency Virus Type 1 Are Associated with Interclade Polymorphisms and Intraclade Phylogenetic Clustering', Journal of Virology, 83, pp. 4605 - 4615, http://jvi.asm.org/content/85/9/4635
,2009, 'Human immunodeficiency virus type 1-specific CD8+ T-cell responses during primary infection are major determinants of the viral set point and loss of CD4+ T cells', Journal of Virology, 83, pp. 7641 - 7648
,2009, 'Proliferation of weakly suppressive regulatory CD4+ T cells is associated with over-active CD4+ T-cell responses in HIV-positive patients with mycobacterial immune restoration disease', European Journal of Immunology, 39, pp. 391 - 403, http://dx.doi.org/10.1002/eji.200838630
,2009, 'Retroviral delivery of promoter-targeted shRNA induces long-term silencing of HIV-1 transcription', Microbes and Infection, 11, pp. 500 - 508
,2009, 'Transcriptional regulation by promoter targeted RNAs', Current Topics in Medicinal Chemistry, 9, pp. 1079 - 1087
,2009, 'Transmission and long-term stability of compensated CD8 escape mutations', Journal of Virology, 83, pp. 3993 - 3997
,2009, 'Trials and tribulations of HIV vaccines', Future Hiv Therapy, 3, pp. 145 - 160
,2009, 'Unusual association of diseases/symptoms: A case of severe visceral leishmaniasis resulting from travel to Greece', BMJ Case Reports, http://dx.doi.org/10.1136/bcr.06.2009.2036
,2008, 'The effect of antiretroviral treatment of different durations in primary HIV infection.', AIDS, 22, pp. 2441 - 2450, http://dx.doi.org/10.1097/QAD.0b013e328319ea4e
,2008, 'Changes in CCR5+ cells and antigen-specific CD4+ T-cells during monotherapy with a CCR5 antagonist SCH532706 compared with combination therapy', Journal of the International AIDS Society, 11, http://dx.doi.org/10.1186/1758-2652-11-s1-p297
,2008, 'Gender differences in HIV progression to AIDS and death in industrialized countries: Slower disease progression following HIV seroconversion in women', American Journal of Epidemiology, 168, pp. 532 - 540, http://dx.doi.org/10.1093/aje/kwn179
,2008, 'Changes in the risk of death after HIV seroconversion compared with mortality in the general population.', JAMA, 300, pp. 51 - 59, http://dx.doi.org/10.1001/jama.300.1.51
,2008, 'Regulatory T cells in HIV infection: Who's suppressing what?', Current Infectious Disease Reports, 10, pp. 252 - 258, http://dx.doi.org/10.1007/s11908-008-0041-8
,2008, 'Regulatory T cells in HIV infection: Who's suppressing what?', Current HIV AIDS Reports, 5, pp. 20 - 26, http://dx.doi.org/10.1007/s11904-008-0004-6
,2008, 'HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis', Lancet, 372, pp. 1894 - 1905, http://dx.doi.org/10.1016/S0140-6736(08)61592-5
,2008, 'Accelerated age-dependent transition of human regulatory T cells to effector memory phenotype', International Immunology, 20, pp. 375 - 383, http://dx.doi.org/10.1093/intimm/dxm151
,2008, 'Closed chromatin architecture is induced by an RNA duplex targeting the HIV-1 promoter region', The Journal of Biological Chemistry, 283, pp. 23353 - 23363
,2008, 'Controlling HIV infection HIV co-receptor gets the finger', Immunology and Cell Biology, 86, pp. 641 - 642
,2008, 'Effect of Rosiglitazone on Peroxisome Proliferator-Activated Receptor gamma Gene Expression in Human Adipose Tissue Is Limited by Antiretroviral Drug-Induced Mitochondrial Dysfunction', Journal of Infectious Diseases, 198, pp. 1794 - 1803
,2008, 'Human leukocyte antigen class I-restricted activation of CD8(+) T cells provides the immunogenetic basis of a systemic drug hypersensitivity', Immunity, 28, pp. 822 - 832, http://dx.doi.org/10.1016/j.immuni.2008.04.020
,2008, 'Low pre-infection levels and loss of central memory CD4+T cells may predict rapid progression in SIV-infected pigtail macaques', Virology, 381, pp. 11 - 15
,2008, 'Marked epitope- and allele- specific differences in rates of mutation in human immunodeficiency type 1 (HIV-1) Gag, Pol, and Nef cytotoxic T-lymphocyte epitopes in acute/early HIV-1 infection', Journal of Virology, 82, pp. 9216 - 9227
,2008, 'Promoter-targeted siRNAs induce gene silencing of simian immunodeficiency virus (SIV) infection in vitro', Molecular Therapy, 16, pp. 565 - 570, http://dx.doi.org/10.1038/sj.mt.6300380
,2008, 'Regulatory T cell abnormalities are associated with aberrant CD4+ T cell responses in patients with immune inflammatory syndrome (IRIS)', Clinical Immunology, 127, pp. S126 - S127, http://dx.doi.org/10.1016/j.ctim.2008.03.359
,2008, 'Restoration of anti-tetanus toxoid responses in patients initiating highly active antiretroviral therapy with or without a boost immunization: an INITIO substudy', Clinical and Experimental Immunology, 152, pp. 252 - 257, http://dx.doi.org/10.1111/j.1365-2249.2008.03611.x
,2008, 'Safety, immunogenicity and efficacy of peptide-pulsed cellular immunotherapy in macaques.', Journal of Medical Primatology, 37, pp. 69 - 78
,2008, 'T-cell responses in primary HIV-1 infection. .', Current opinion in HIV & AIDS, 3, pp. 52 - 59
,2008, 'TCR beta-chain sharing in human CD8+ T cell responses to cytomegalovirus and EBV', Journal of Immunology, 181, pp. 7853 - 7862
,2008, 'Trends in antiretroviral treatment use and treatment response in three Australian states in the first decade of combination antiretroviral treatment', Sexual Health, 5, pp. 141 - 154
,2008, 'Virologic determinants of success after structured treatment interruptions in antiretrovirals in acute HIV-1 infection', JAIDS: Journal of Acquired Immune Deficiency Syndromes, 47, pp. 140 - 147
,2007, 'Computationally efficient multidimensional analysis of complex flow cytometry data using second order polynomial histograms', Cytometry Part A, 89, pp. 44 - 58, http://dx.doi.org/10.1002/cyto.a.22704
,2007, 'Acutely dysregulated, chronically disabled by the enemy within: T-cell responses to HIV-1 infection', Immunology and Cell Biology, 85, pp. 6 - 15
,2007, 'Antiretroviral therapy with the integrase inhibitor raltegravir alters decay kinetics of HIV, significantly reducing the second phase', AIDS, 21, pp. 2315 - 2321
,2007, 'Escape from the Dominant HLA-B27-Restricted Cytotoxic T-Lymphocyte Response in Gag Is Associated with a Dramatic Reduction in Human Immunodeficiency Virus Type 1 Replication', Journal of Virology, 81, pp. 12382 - 12393
,2007, 'Influence of IFN gamma co-expression on the safety and antiviral efficacy of recombinant fowlpox virus HIV therapeutic vaccines following interruption of antiretroviral therapy', Human Vaccines, 3, pp. 260 - 267
,2007, 'Rapid Reversion of Sequence Polymorphisms Dominates Early Human Immunodeficiency Virus Type 1 Evolution', Journal of Virology, 81, pp. 193 - 201
,2007, 'Recognition of a defined region within p24 Gag by CD8(+) T cells during primary human immunodeficiency virus type I infection in individuals expressing protective HLA class I alleles', Journal of Virology, 81, pp. 7725 - 7731
,2007, 'Substantial improvements in performance indicators achieved in a peripheral blood mononuclear cell cryopreservation quality assurance program using single donor samples', Clinical and Vaccine Immunology, 14, pp. 52 - 59
,2007, 'T cell receptor b-chain sharing in human CD8+ T cell responses to cytomegalovirus and Epstein-Barr virus', Journal of Immunology, 181, pp. 7853 - 7862
,2007, 'Three-year immune reconstitution in PI-sparing and PI-containing antiretroviral regimens in advanced HIV-1 disease', Antiviral Therapy, 12, pp. 553 - 558
,2007, 'Upregulation of CTLA-4 by HIV-specific CD4(+) T cells correlates with disease progression and defines a reversible immune dysfunction', Nature Immunology, 8, pp. 1246 - 1254
,2007, 'Validation of RNA-based molecular clonotype analysis for virus-specific CD8+ T-cells in formaldehyde-fixed specimens isolated from peripheral blood', Journal of Immunological Methods, 326, pp. 127 - 138, http://dx.doi.org/10.1016/j.jim.2007.07.016
,